Biodistribution of Intratracheal, Intranasal, and Intravenous Injections of Human Mesenchymal Stromal Cell-Derived Extracellular Vesicles in a Mouse Model for Drug Delivery Studies
Mesenchymal stromal cell-derived extracellular vesicles (MSC-EVs) are extensively studied as therapeutic tools. Evaluation of their biodistribution is fundamental to understanding MSC-EVs’ impact on target organs. In our work, MSC-EVs were initially labeled with DiR, a fluorescent lipophilic dye, an...
| Main Authors: | , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2023-02-01
|
| Series: | Pharmaceutics |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1999-4923/15/2/548 |
| _version_ | 1827755904294977536 |
|---|---|
| author | Anna Maria Tolomeo Gaia Zuccolotto Ricardo Malvicini Giada De Lazzari Alessandro Penna Chiara Franco Federico Caicci Fabio Magarotto Santina Quarta Michela Pozzobon Antonio Rosato Maurizio Muraca Federica Collino |
| author_facet | Anna Maria Tolomeo Gaia Zuccolotto Ricardo Malvicini Giada De Lazzari Alessandro Penna Chiara Franco Federico Caicci Fabio Magarotto Santina Quarta Michela Pozzobon Antonio Rosato Maurizio Muraca Federica Collino |
| author_sort | Anna Maria Tolomeo |
| collection | DOAJ |
| description | Mesenchymal stromal cell-derived extracellular vesicles (MSC-EVs) are extensively studied as therapeutic tools. Evaluation of their biodistribution is fundamental to understanding MSC-EVs’ impact on target organs. In our work, MSC-EVs were initially labeled with DiR, a fluorescent lipophilic dye, and administered to BALB/c mice (2.00 × 10<sup>10</sup> EV/mice) through the following routes: intravenous (IV), intratracheal (IT) and intranasal (IN). DiR-labeled MSC-EVs were monitored immediately after injection, and after 3 and 24 hours (h). Whole-body analysis, 3 h after IV injection, showed an accumulation of MSC-EVs in the mice abdominal region, compared to IT and IN, where EVs mainly localized at the levels of the chest and brain region, respectively. After 24 h, EV-injected mice retained a stronger positivity in the same regions identified after 3 h from injection. The analyses of isolated organs confirmed the accumulation of EVs in the spleen and liver after IV administration. Twenty-four hours after the IT injection of MSC-EVs, a stronger positivity was detected selectively in the isolated lungs, while for IN, the signal was confined to the brain. In conclusion, these results show that local administration of EVs can increase their concentration in selective organs, limiting their systemic biodistribution and possibly the extra-organ effects. Biodistribution studies can help in the selection of the most appropriate way of administration of MSC-EVs for the treatment of different diseases. |
| first_indexed | 2024-03-11T08:16:37Z |
| format | Article |
| id | doaj.art-2b8b98aefd0d4e12be24a82d82b3db69 |
| institution | Directory Open Access Journal |
| issn | 1999-4923 |
| language | English |
| last_indexed | 2024-03-11T08:16:37Z |
| publishDate | 2023-02-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Pharmaceutics |
| spelling | doaj.art-2b8b98aefd0d4e12be24a82d82b3db692023-11-16T22:41:27ZengMDPI AGPharmaceutics1999-49232023-02-0115254810.3390/pharmaceutics15020548Biodistribution of Intratracheal, Intranasal, and Intravenous Injections of Human Mesenchymal Stromal Cell-Derived Extracellular Vesicles in a Mouse Model for Drug Delivery StudiesAnna Maria Tolomeo0Gaia Zuccolotto1Ricardo Malvicini2Giada De Lazzari3Alessandro Penna4Chiara Franco5Federico Caicci6Fabio Magarotto7Santina Quarta8Michela Pozzobon9Antonio Rosato10Maurizio Muraca11Federica Collino12Department of Cardiac, Thoracic and Vascular Science and Public Health, University of Padova, 35128 Padua, ItalyIstituto Oncologico Veneto IOV-Istituto di Ricovero e Cura a Carattere Scientifico IRCCS, 35128 Padua, ItalyL.i.f.e.L.a.b. Program, Consorzio per la Ricerca Sanitaria (CORIS), Veneto Region, 35128 Padua, ItalyL.i.f.e.L.a.b. Program, Consorzio per la Ricerca Sanitaria (CORIS), Veneto Region, 35128 Padua, ItalyDepartment of Surgery, Oncology and Gastroenterology, University of Padova, 35128 Padua, ItalyRheumatology Unit, Department of Medicine (DIMED), University of Padova, 35128 Padua, ItalyDepartment of Biology, University of Padova, 35131 Padua, ItalyDepartment of Women’s and Children’s Health, University of Padova, 35128 Padua, ItalyDepartment of Medicine, University of Padova, 35128 Padua, ItalyDepartment of Women’s and Children’s Health, University of Padova, 35128 Padua, ItalyIstituto Oncologico Veneto IOV-Istituto di Ricovero e Cura a Carattere Scientifico IRCCS, 35128 Padua, ItalyL.i.f.e.L.a.b. Program, Consorzio per la Ricerca Sanitaria (CORIS), Veneto Region, 35128 Padua, ItalyLaboratory of Translational Research in Paediatric Nephro-Urology, Department of Clinical Sciences and Community Health, University of Milano, 20122 Milan, ItalyMesenchymal stromal cell-derived extracellular vesicles (MSC-EVs) are extensively studied as therapeutic tools. Evaluation of their biodistribution is fundamental to understanding MSC-EVs’ impact on target organs. In our work, MSC-EVs were initially labeled with DiR, a fluorescent lipophilic dye, and administered to BALB/c mice (2.00 × 10<sup>10</sup> EV/mice) through the following routes: intravenous (IV), intratracheal (IT) and intranasal (IN). DiR-labeled MSC-EVs were monitored immediately after injection, and after 3 and 24 hours (h). Whole-body analysis, 3 h after IV injection, showed an accumulation of MSC-EVs in the mice abdominal region, compared to IT and IN, where EVs mainly localized at the levels of the chest and brain region, respectively. After 24 h, EV-injected mice retained a stronger positivity in the same regions identified after 3 h from injection. The analyses of isolated organs confirmed the accumulation of EVs in the spleen and liver after IV administration. Twenty-four hours after the IT injection of MSC-EVs, a stronger positivity was detected selectively in the isolated lungs, while for IN, the signal was confined to the brain. In conclusion, these results show that local administration of EVs can increase their concentration in selective organs, limiting their systemic biodistribution and possibly the extra-organ effects. Biodistribution studies can help in the selection of the most appropriate way of administration of MSC-EVs for the treatment of different diseases.https://www.mdpi.com/1999-4923/15/2/548extracellular vesiclesbiodistributionpharmacokineticsdrug delivery |
| spellingShingle | Anna Maria Tolomeo Gaia Zuccolotto Ricardo Malvicini Giada De Lazzari Alessandro Penna Chiara Franco Federico Caicci Fabio Magarotto Santina Quarta Michela Pozzobon Antonio Rosato Maurizio Muraca Federica Collino Biodistribution of Intratracheal, Intranasal, and Intravenous Injections of Human Mesenchymal Stromal Cell-Derived Extracellular Vesicles in a Mouse Model for Drug Delivery Studies Pharmaceutics extracellular vesicles biodistribution pharmacokinetics drug delivery |
| title | Biodistribution of Intratracheal, Intranasal, and Intravenous Injections of Human Mesenchymal Stromal Cell-Derived Extracellular Vesicles in a Mouse Model for Drug Delivery Studies |
| title_full | Biodistribution of Intratracheal, Intranasal, and Intravenous Injections of Human Mesenchymal Stromal Cell-Derived Extracellular Vesicles in a Mouse Model for Drug Delivery Studies |
| title_fullStr | Biodistribution of Intratracheal, Intranasal, and Intravenous Injections of Human Mesenchymal Stromal Cell-Derived Extracellular Vesicles in a Mouse Model for Drug Delivery Studies |
| title_full_unstemmed | Biodistribution of Intratracheal, Intranasal, and Intravenous Injections of Human Mesenchymal Stromal Cell-Derived Extracellular Vesicles in a Mouse Model for Drug Delivery Studies |
| title_short | Biodistribution of Intratracheal, Intranasal, and Intravenous Injections of Human Mesenchymal Stromal Cell-Derived Extracellular Vesicles in a Mouse Model for Drug Delivery Studies |
| title_sort | biodistribution of intratracheal intranasal and intravenous injections of human mesenchymal stromal cell derived extracellular vesicles in a mouse model for drug delivery studies |
| topic | extracellular vesicles biodistribution pharmacokinetics drug delivery |
| url | https://www.mdpi.com/1999-4923/15/2/548 |
| work_keys_str_mv | AT annamariatolomeo biodistributionofintratrachealintranasalandintravenousinjectionsofhumanmesenchymalstromalcellderivedextracellularvesiclesinamousemodelfordrugdeliverystudies AT gaiazuccolotto biodistributionofintratrachealintranasalandintravenousinjectionsofhumanmesenchymalstromalcellderivedextracellularvesiclesinamousemodelfordrugdeliverystudies AT ricardomalvicini biodistributionofintratrachealintranasalandintravenousinjectionsofhumanmesenchymalstromalcellderivedextracellularvesiclesinamousemodelfordrugdeliverystudies AT giadadelazzari biodistributionofintratrachealintranasalandintravenousinjectionsofhumanmesenchymalstromalcellderivedextracellularvesiclesinamousemodelfordrugdeliverystudies AT alessandropenna biodistributionofintratrachealintranasalandintravenousinjectionsofhumanmesenchymalstromalcellderivedextracellularvesiclesinamousemodelfordrugdeliverystudies AT chiarafranco biodistributionofintratrachealintranasalandintravenousinjectionsofhumanmesenchymalstromalcellderivedextracellularvesiclesinamousemodelfordrugdeliverystudies AT federicocaicci biodistributionofintratrachealintranasalandintravenousinjectionsofhumanmesenchymalstromalcellderivedextracellularvesiclesinamousemodelfordrugdeliverystudies AT fabiomagarotto biodistributionofintratrachealintranasalandintravenousinjectionsofhumanmesenchymalstromalcellderivedextracellularvesiclesinamousemodelfordrugdeliverystudies AT santinaquarta biodistributionofintratrachealintranasalandintravenousinjectionsofhumanmesenchymalstromalcellderivedextracellularvesiclesinamousemodelfordrugdeliverystudies AT michelapozzobon biodistributionofintratrachealintranasalandintravenousinjectionsofhumanmesenchymalstromalcellderivedextracellularvesiclesinamousemodelfordrugdeliverystudies AT antoniorosato biodistributionofintratrachealintranasalandintravenousinjectionsofhumanmesenchymalstromalcellderivedextracellularvesiclesinamousemodelfordrugdeliverystudies AT mauriziomuraca biodistributionofintratrachealintranasalandintravenousinjectionsofhumanmesenchymalstromalcellderivedextracellularvesiclesinamousemodelfordrugdeliverystudies AT federicacollino biodistributionofintratrachealintranasalandintravenousinjectionsofhumanmesenchymalstromalcellderivedextracellularvesiclesinamousemodelfordrugdeliverystudies |